William B. Smith

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*

Dennis Vargo, William G. Kramer, Paula Black et al. · Clinical Pharmacology & Therapeutics · 1995 · 302 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure

Lisa C. Costello‐Boerrigter, William B. Smith, Guido Boerrigter et al. · American Journal of Physiology-Renal Physiology · 2005 · 259 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor

Arthur Bergman, Josée Côté, Bingming Yi et al. · Diabetes Care · 2007 · 195 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Interpretation of carbon-13 NMR spectra

William B. Smith · Journal of Magnetic Resonance (1969) · 1989 · 187 citations

Natural Sciences, Biochemistry, Chemistry +11